MarketScreener Strategies Hansoh Pharmaceutical Group Company Limited
Equities
3692
KYG549581067
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.16 HKD | -1.51% |
|
-6.69% | -2.55% |
| 05-14 | Hansoh Pharma Gets China Nod for Trial of Tumor Drug | MT |
| 05-13 | Hansoh pharmaceutical says HS-10541 tablets obtain clinical trial approval from China's NMPA | RE |
MarketScreener Strategies
Search
 | Hansoh Pharmaceutical: The silent revolution in Chinese biopharma | May 16, 2025 at 12:44 pm |
 | Hansoh Pharmaceutical Group Company Limited : Regulator grants breakthrough-therapy status to lung cancer drug | December 03, 2024 at 05:31 pm |
No results for this search
Filters
- Stock Market
- Equities
- 3692 Stock
- News Hansoh Pharmaceutical Group Company Limited
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition